
==== Front
J Parasitol Res
J Parasitol Res
jpr
Journal of Parasitology Research
2090-0023
2090-0031
Hindawi

10.1155/2024/3476951
Review Article
Wolbachia and Lymphatic Filarial Nematodes and Their Implications in the Pathogenesis of the Disease
https://orcid.org/0009-0005-5950-5438
Setegn Abebaw abebawsetegn@gmail.com
1
https://orcid.org/0009-0001-4803-1514
Amare Gashaw Azanaw 2
https://orcid.org/0009-0001-3797-6096
Mihret Yenesew 1
1Department of Medical Parasitology, University of Gondar, Gondar, Ethiopia
2Department of Medical Laboratory Sciences, Debre Markos University, Debre Markos, Ethiopia
Academic Editor: Bernard Marchand

2024
2 5 2024
2024 34769513 1 2024
15 4 2024
20 4 2024
Copyright © 2024 Abebaw Setegn et al.
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Lymphatic filariasis (LF) is an infection of three closely related filarial worms such as Wuchereria bancrofti, Brugia malayi, and Brugia timori. These worms can cause a devastating disease that involves acute and chronic lymphoedema of the extremities, which can cause elephantiasis in both sexes and hydroceles in males. These important public health nematodes were found to have a mutualistic relationship with intracellular bacteria of the genus Wolbachia, which is essential for the development and survival of the nematode. The host's inflammatory response to parasites and possibly also to the Wolbachia endosymbiont is the cause of lymphatic damage and disease pathogenesis. This review tried to describe and highlight the mutualistic associations between Wolbachia and lymphatic filarial nematodes and the role of bacteria in the pathogenesis of lymphatic filariasis. Articles for this review were searched from PubMed, Google Scholar, and other databases. Article searching was not restricted by publication year; however, only English version full-text articles were included.
==== Body
pmc1. Introduction

Lymphatic filariasis is a neglected tropical disease caused by the filarial nematodes of Wuchereria bancrofti, Brugia malayi, and Brugia timori [1, 2], which are transmitted through the bite of mosquitoes of the genus Anopheles, Aedes, Culex, and Mansonia [2].

Lymphatic filariasis is the second main parasitic cause of disability with an estimated 5.549 million disability-adjusted life years [3], and about 51 million people are affected worldwide [4]. Filariasis caused by W. bancrofti accounts for approximately 90% of cases of lymphatic filariasis, and the remaining 10% is caused by the two Brugia species [5]. The clinical manifestation of the disease can range from severe swelling, usually in the limbs (lymphedema) or scrotal sac (hydrocele), to occurrences of acute adenolymphangitis [1]. These complications of lymphatic filariasis cause substantial morbidity in the world [6]. Additionally, this illness increases susceptibility to opportunistic infections [7], especially when lymphedema from a persistent filarial infection advances. Opportunistic microorganisms that cause long-term recurrent secondary infections are what lead to the development of elephantiasis [8].

Community-level transmission of lymphatic filariasis can be limited by mass therapy with prescribed oral regimens of antihelminthic drugs such as albendazole, alone or with ivermectin, or diethylcarbamazine citrate and albendazole, or a combination of all three [9, 10].

Wolbachia are obligate endosymbiotic α-proteobacteria that are polymorphic and closely related to other rickettsial organisms such as Rickettsia, Ehrlichia, and Anaplasma [11, 12]. Current evidence in filarial research reveals that endosymbiotic Wolbachia bacteria play a significant role in the biology of filarial nematodes [13]. The symbiotic associations of Wolbachia and its role in the pathogenesis of lymphatic filariasis are discussed below.

2. Mutualistic Association between Wolbachia and Lymphatic Filarial Nematodes

An intimate type of symbiotic interaction known as endosymbiosis occurs when one organism lives inside the body of another, establishing a range of relationships from parasitism to compulsory mutualism [14].

Wolbachia is a common and abundant endosymbiotic bacteria that lives in the vacuoles of host germline and somatic cells and is found in arthropods and filarial nematodes [15].

Wolbachia spreads vertically from the mother to the offspring in both nematodes and arthropods. These bacteria are present in oocytes before fertilization; during host development, differences in the tropism of certain Wolbachia are noted; nevertheless, the female reproductive system is a common site in all animal hosts [16]. In filarial nematodes, somatic tissues, such as the lateral cords, are also heavily colonized in addition to their placement in the ovary, which is crucial for maternal transmission [17].

It has been demonstrated that Wolbachia is present in the majority of filarial worms that cause serious sickness in both humans and animals, including W. bancrofti, B. malayi, Onchocerca volvulus, Dirofilaria immitis, and Dirofilaria repens [17].

Wolbachia has the ability to significantly alter hosts' biology. It can identify changes in host reproduction in arthropods, such as parthenogenesis, feminization of genetic males, male embryo death, and cytoplasmic incompatibility (CI) [16]. Furthermore, there are unusual Wolbachia-insect partnerships in which the bacteria is necessary for host reproduction. Thus, there is evidence that Wolbachia is not only involved in the changing of host reproduction, but it also seems to be necessary for the host arthropod in certain circumstances. There exist instances of bacteria-insect relationships where the bacteria have a role in controlling iron homeostasis [18], or in other circumstances, these symbionts provide defense against viral infections [19].

It is most likely connected to the induction of insect immunity that Wolbachia offers as a defense mechanism against insect viruses. Recent research has demonstrated that infecting Aedes aegypti with the Wolbachia popcorn strain strongly activates the mosquito's immunity, which in turn protects the insect against infections by parasites including malaria and filarial worms [20, 21]. Wolbachia bacteria have also been found in filarial nematodes of animals, including filariae infecting cattle (Onchocerca gutturosa and Onchocerca lienalis) [22, 23].

The bacteria is found to be an obligatory symbiont in filarial worms and is needed for nematode development, reproduction, and long-term survival. This is supported by pioneer studies, which stated that treatments with antibiotics directed against the bacteria (tetracycline and its derivatives) had a number of harmful effects on the host nematode; the most notable effects were inhibition of embryogenesis and the production of microfilaria, as well as inhibition of development from infectious larvae (L3) to adults. Adulticide effects were also found in one of these groundbreaking research, including the cow filarial Onchocerca ochengi [22].

Wolbachia exhibit a wide range of symbiotic relationships with their hosts, from commensal, parasitic, or harmful relationships with insects and other arthropod hosts to obligate mutualism in filarial nematodes [15].

The deoxyribonucleic acid (DNA) sequencing data revealed that W. bancrofti and B. malayi, which are the primary species for lymphatic filariasis, were found to include an internal bacterium that resembled Wolbachia [24]. Furthermore, these lymphatic filarial nematodes were found to be infected with Wolbachia [25]. All stages of the life cycle of filarial worms are infected with this bacteria, but the severity of infections differs between different stages of the nematodes [26, 27].

This obligate mutualistic symbiosis relationship between Wolbachia and filarial worms [28] is based on metabolic complementarity and increases or strengthens one or both host's biochemical variety and pathways [29, 30]. For instance, Wolbachia is necessary for healthy larval growth and development, embryogenesis, and adult worm survival [17], while the nematode host provides the amino acids required for the bacteria's growth [28].

Data from the sequencing of the genomes of both Wolbachia (wBm) and its nematode host B. malayi revealed that for a wide variety of biological processes, including the synthesis of metabolites such as haem, riboflavin, flavin adenine dinucleotide, and nucleotides, Wolbachia provides to nematodes because they cannot synthesize these molecules on their own [28].

In addition, there are biological processes such as the growth and development of larvae and adult female embryogenesis; the nematode's rapid growth, development, and organogenesis; and its association with the rapid expansion of Wolbachia populations following larval infection of mammalian hosts and in reproductively active adult females which are impossible in the absence of Wolbachia because all these activities have a high metabolic demand [26].

On the other hand, due to the absence of Wolbachia, extensive apoptosis occurs in the germline and somatic cells of embryos, microfilariae, and fourth-stage larvae. This is most likely because these cells and tissues do not have critical nutrients or metabolites that would prevent apoptosis [31].

Furthermore, a comparison of genomes also indicates that Wolbachia shows a metabolic dependence on the nematode host in numerous vitamins and cofactors for its growth, including coenzyme A, nicotinamide adenine dinucleotide, biotin, ubiquinone, folate, lipoic acid, and pyridoxal phosphate, which the bacteria did not synthesize de novo [28]. Wolbachia also has importance for the filarial nematodes in which the bacteria has an enzyme called Wolbachia catalase, which might protect both the host of the nematode and the bacteria from oxidative damage [32].

In general, since Wolbachia spread vertically through oocytes in filarial nematodes, the internal endosymbiont will be absent after worm sterilization. Therefore, the viability of the filarial worms will be affected without Wolbachia. This makes the bacteria a fascinating target for filarial medication treatment due to all of these characteristics [31]. This is supported by a number of studies in both animal and in vitro settings, which showed that Wolbachia are a promising therapeutic target for human filariasis [17].

Early preclinical researches revealed that adult filarial worms may die, experience developmental retardation, and experience embryotoxicity as a result of antibiotic therapy directed against the endosymbiont bacteria [33]. The adult germline and somatic cells in the embryos and microfilariae undergo substantial apoptosis as a result of the subsequent depletion of Wolbachia, which sterilizes the filarial nematodes [31]. As a result, it seemed that Wolbachia was the ideal target for treating human filarial diseases [34].

3. The Implications of Wolbachia in the Pathogenesis of Lymphatic Filariasis

Lymphatic filarial worms can cause a variety of infection manifestations related to serious and long-lasting inflammation [35]. The main source of knowledge on the role of Wolbachia in the pathogenesis of human lymphatic filarial infections is research on the molecular pathogenesis of inflammation caused by filarial worms [36].

The stimulation of proinflammatory and immunomodulatory processes in the host is one way that Wolbachia is involved in the infection process, from the acute phase to the development of chronic problems [36]. A defense mechanism against molecular structures that are shared by many different types of organisms is the innate immune system. It involves identifying certain “markers,” or pathogen-associated molecular patterns (PAMPs), that indicate the existence of “generic” pathogens [37].

Subsequently, Toll-like receptors (TLRs) on the surface of antigen-presenting cells recognize these PAMPs, and proinflammatory cytokines and reactive oxygen species are produced, along with an upregulation of costimulatory molecules that aid in the development of an adaptive immune response [37]. Both Th1-adaptive immune responses and innate inflammatory responses may be activated by the release of Wolbachia lipoprotein [38].

Wolbachia is discharged after the worm dies in hosts infected with filarial nematodes carrying the bacteria through a larval moult, natural attrition, microfilarial turnover, and pharmaceutical interventions. The release of the bacteria is involved in both increasing inflammatory-mediated pathogenesis and the hyporesponsiveness of the immune system [17].

The bacteria can cause an inflammatory response by interacting with immune cells such as neutrophils, dendritic cells, and monocytes or macrophages [39]. This role can be simulated in vitro by exposing innate immune cells to parasite extracts. Antigen-presenting cells challenged with complete Wolbachia-containing worm extracts produce significant amounts of inflammatory cytokines, while stimulation with Wolbachia antibiotic-depleted worm extracts or with Wolbachia-free filariae extracts does not result in such a reaction [38, 40, 41].

Additionally, a number of molecular pattern possibilities associated with pathogens for Wolbachia have been shown to modulate the inflammatory response, such as diacylated lipoproteins, which promote Th1 polarization and the innate inflammatory response [38]. The bacteria also prevents eosinophils from degranulating, which is necessary for the eradication of filarial infections. This affects the neutrophil response of the host. By providing immunity against the fatal effector cell response, Wolbachia's modulation of the local inflammatory response prolongs the life of the nematode host through defensive mutualism [42].

Patients with human lymphatic filariasis with B. malayi experience severe systemic inflammatory reactions that are strongly correlated with the discharge of bacteria into their blood after antifilarial therapy of worms [43]. This gives concrete proof that upon the death of the nematode, Wolbachia is released into the blood and exposed to the host's immune systems. Studies in B. malayi-infected animals have revealed a further connection between immunological reactions to bacteria and the emergence of lymphatic filarial diseases [43].

A Wolbachia surface protein (WSP) and the antibody response to the protein are correlated with the onset and duration of episodes of inflammatory lymphedema [44]. This result supports the hypothesis that innate and acquired immune responses to endosymbiont bacteria could be involved in the pathogenesis of lymphatic filarial disease because endosymbiont antigens are recognized by the acquired immune response [45].

By activation of Toll-like receptors-2 (TLR-2) with extracts of B. malayi, lymphangiogenic factors such as angiopoietin-1 and vascular endothelial growth factor are also produced [46]. The severity of the infection was found to be correlated with the increased levels of these lymphangiogenic agents [46, 47]. The innate immune receptor TLR-4 identifies and binds to lipopolysaccharide (LPS), an antigenic element of gram-negative bacteria's outer leaflet [48].

Following ligand attachment, TLR-4 triggers a signaling cascade that activates critical intracellular transcription factors such as interferon response factor (IRF), activator protein-1 (AP-1), and nuclear factor kappa B (NF-κB) [49]. It has been discovered that the filarial nematode's bestrophin homolog and Wolbachia endosymbiont's LPS serve as ligands for TLR-4, causing inflammation in the macrophage population and ultimately causing filarial lymphedema [50].

Recent reports revealed the existence of a novel Toll-like receptor-4 (TLR-4) ligand called microfilarial protein (MfP) from the sheath of microfilariae (the larval form) of the human filarial worm W. bancrofti. The microfilarial protein activates the TLR-4-NF-κB pathway in macrophages, causing a proinflammatory response [50]. Antagonists of lipid A are found to prevent pattern recognition receptors CD14 and TLR-4 from activating innate inflammatory responses [39]. When worms are treated with an antifilarial medication in human filariasis, the release of bacteria into the blood is highly linked to severe systemic inflammatory reactions in patients with B. malayi infection [43].

Proinflammatory cytokines and inflammatory mediators, such as interleukin-1b (IL-1b), IL-6, interferon-ϒ (IFN-ϒ), tumor necrotic factor-α (TNF-α), nitric oxide (NO), and LPS binding protein (LBP), are released in conjunction with adverse drug reactions, which are more common in those individuals with high microfilarial burdens [51–53]. This implies that the discharge of bacteria as a result of parasite death stimulates inflammatory responses, leading to acute inflammatory conditions related to the death of adult worms and adversative reactions to drugs [45].

The existence of significant concentrations of inflammatory cytokines, like IL-1b, IL-6, IL-8, TNF-a, and granulocyte-macrophage colony-stimulating factors in fluids from limb lymphoedema and hydroceles, provides evidence for the involvement of inflammatory responses in the development of chronic disease [54].

Anti-inflammatory mediators such as IL-4, IL-10, IL-13, transforming growth factor- (TGF-) β, IL-1RA, glucocorticoids, prostaglandin E-2, and proinflammatory cytokine soluble receptors control the generation of proinflammatory responses after exposure to lipopolysaccharide (LPS) [55]. Although this is supposed to shield against the uncontrolled immune activation of acute endotoxic shock, it can lead to an inability to respond appropriately to secondary infections in survivors of endotoxic shock [45].

Moreover, the innate immune system cells may become desensitized because of the chronic release of Wolbachia. This chronic release, besides the harm caused by acute inflammatory episodes to the structure and functionality of parasitized lymphatics, would reassure the emergence of environmental opportunistic infections such as those that arise during acute dermatolymphangioadenitis (ADLA), which in turn is linked to chronic lymphodema and elephantiasis (Figure 1) [56, 57].

Anti-Wolbachia doxycycline treatment has led to a reduction in scrotal lymphatic vessel enlargement in patients with W. Bancrofti infection, which was indicative of an improvement in symptoms of the disease [58]. This provides evidence in favor of using Wolbachia as a therapeutic target for the treatment of filarial pathology that doxycycline may have a healing effect in patients with filarial pathology [59].

Doxycycline also has effects on filarial worms, independent of Wolbachia bacteria. This is supported by in vivo studies on the effects of doxycycline on gene expression in Wolbachia and Brugia malayi adult female worms which state that the drug has effects on the downregulation of B. malayi genes which are involved in the development and reproduction of embryos. These genes are necessary for growth, development, and reproduction [60].

However, following doxycycline therapy, there were enhanced expression signals for numerous B. malayi genes related to energy synthesis, electron transport, metabolism, antioxidants, and other unknown functions. These findings imply that, although without the ability to reproduce, female worms are able to compensate for the loss of Wolbachia in order to survive [60].

Furthermore, an extremely efficient way to keep an eye on human filariasis infections would be to target Wolbachia. In 2009, the first computational attempt was made to pinpoint the vital genes of the endosymbiotic bacterium Wolbachia, which is not cultivable [61].

Currently, the whole genome of Wolbachia from Brugia malayi (wBm) is already available, which may be used to determine the best treatment targets in wBm using a hierarchical proteome subtractive method [28]. Some of the potential drug targets of Wolbachia endosymbiont (Brugia malayi) are outer membrane protein, N5-carboxyaminoimidazole ribonucleotide synthase, and UDP-N-acetylenolpyruvoylglucosamine reductase [62].

4. Conclusions

As we have discussed in our review, we found that Wolbachia bacteria play a necessary role in the biology of lymphatic filarial nematodes. The symbiotic association between the bacteria and filarial nematodes is crucial for biological processes, such as transmission through the vector and the longevity of adult worms, in addition to the high metabolic demand during growth and development. Several studies on the inflammation-based lymphatic filariasis pathogenesis have revealed that the main inflammatory provocation for lymphatic filarial worms is endotoxin-like action obtained from endosymbiont bacteria, and Wolbachia bacterial genes become the main drug targets in human filariasis infections.

Data Availability

All relevant data are fully available without restriction within the manuscript.

Conflicts of Interest

The authors report that they have no conflicts of interest in this work.

Authors' Contributions

AS participated in the conception, manuscript draft, design, manuscript writing-up, manuscript editing, and validation. GA was involved in language editing and manuscript editing. YM participated in the editing and conception of the manuscript. All authors have agreed on the journal to which the article has been submitted, gave final approval for the version to be published, and agreed to be responsible for all aspects of the work.

Figure 1 Schematic representation of Wolbachia bacteria in the development of the immunopathology of lymphatic filarial diseases (adapted from [45]).
==== Refs
1 Ottesen E. A. Lymphatic filariasis: treatment, control and elimination Advances in Parasitology 2006 61 395 441 10.1016/S0065-308X(05)61010-X 2-s2.0-33646823291 16735170
2 Ottesen E. A. Duke B. Karam M. Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis Bulletin of the World Health Organization 1997 75 6 491 503 9509621
3 Fenwick A. The global burden of neglected tropical diseases Public Health 2012 126 3 233 236 10.1016/j.puhe.2011.11.015 2-s2.0-84858154974 22325616
4 Cromwell E. A. Schmidt C. A. Kwong K. T. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis The Lancet Global Health 2020 8 9 e1186 e1194 10.1016/S2214-109X(20)30286-2 32827480
5 Nutman T. B. Insights into the pathogenesis of disease in human lymphatic filariasis Lymphatic Research and Biology 2013 11 3 144 148 10.1089/lrb.2013.0021 2-s2.0-84884497927 24044755
6 WHO Global programme to eliminate lymphatic filariasis: progress report, 2016 Weekly Epidemiological Record 2017 92 40 594 607 28984121
7 Fernando R. L. Fernando S. S. Leong A. S.-Y. Tropical Infectious Diseases: Epidemiology, Investigation, Diagnosis and Management 2001 Cambridge University Press
8 Dreyer G. Noroes J. Figueredo-Silva J. Piessens W. Pathogenesis of lymphatic disease in bancroftian filariasis:: a clinical perspective Parasitology Today 2000 16 12 544 548 10.1016/S0169-4758(00)01778-6 2-s2.0-0034410939 11121854
9 WHO Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes 2011 Geneva World Health Organization
10 Stolk W. A. Swaminathan S. Oortmarssen G. J. das P. K. Habbema J. D. F. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study The Journal of Infectious Diseases 2003 188 9 1371 1381 10.1086/378354 2-s2.0-0242721026 14593597
11 Kozek W. J. Transovarially-transmitted intracellular microorganisms in adult and larval stages of Brugia malayi The Journal of Parasitology 1977 63 6 992 1000 10.2307/3279832 2-s2.0-0017716302 592054
12 Taylor M. J. Bilo K. Cross H. F. Archer J. P. Underwood A. P. 16S rDNA phylogeny and ultrastructural characterization of Wolbachia intracellular bacteria of the filarial nematodes Brugia malayi, B. Pahangi, and Wuchereria bancrofti Experimental Parasitology 1999 91 4 356 361 10.1006/expr.1998.4383 2-s2.0-0032589017 10092480
13 Hübner M. P. Pfarr K. Hoerauf A. Wolbachia endosymbionts as treatment targets for filarial diseases Human and Animal Filariases: Landscape, Challenges, and Control 2022 589 614 10.1002/9783527823413.ch24
14 Manoj R. R. S. Latrofa M. S. Epis S. Otranto D. Wolbachia: endosymbiont of onchocercid nematodes and their vectors Parasites and Vectors 2021 14 1 1 24 10.1186/s13071-021-04742-1 33388087
15 Voronin D. Cook D. A. Steven A. Taylor M. J. Autophagy regulates Wolbachia populations across diverse symbiotic associations Proceedings of the National Academy of Sciences 2012 109 25 E1638 E1E46 10.1073/pnas.1203519109 2-s2.0-84862573586
16 Werren J. H. Baldo L. Clark M. E. Wolbachia: master manipulators of invertebrate biology Nature Reviews Microbiology 2008 6 10 741 751 10.1038/nrmicro1969 2-s2.0-52049111890 18794912
17 Taylor M. J. Bandi C. Hoerauf A. Wolbachia. Bacterial endosymbionts of filarial nematodes Advances in Parasitology 2005 60 245 284 10.1016/S0065-308X(05)60004-8 2-s2.0-26844459599 16230105
18 Kremer N. Voronin D. Charif D. Mavingui P. Mollereau B. Vavre F. Wolbachia interferes with ferritin expression and iron metabolism in insects PLoS Pathogens 2009 5 10, article e1000630 10.1371/journal.ppat.1000630 2-s2.0-73449107773 19851452
19 Teixeira L. Ferreira Á. Ashburner M. The bacterial symbiont Wolbachia induces resistance to RNA viral infections in Drosophila melanogaster PLoS Biology 2008 6 12, article e1000002 10.1371/journal.pbio.1000002 2-s2.0-58149143149 19222304
20 Kambris Z. Cook P. E. Phuc H. K. Sinkins S. P. Immune activation by life-shortening Wolbachia and reduced filarial competence in mosquitoes Science 2009 326 5949 134 136 10.1126/science.1177531 2-s2.0-70349664283 19797660
21 Kambris Z. Blagborough A. M. Pinto S. B. Wolbachia stimulates immune gene expression and inhibits plasmodium development in Anopheles gambiae PLoS Pathogens 2010 6 10, article e1001143 10.1371/journal.ppat.1001143 2-s2.0-78449261793 20949079
22 Langworthy N. G. Renz A. Mackenstedt U. Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship Proceedings of the Royal Society of London. Series B: Biological Sciences 2000 267 1448 1063 1069 10.1098/rspb.2000.1110 2-s2.0-0343151069 10885510
23 Townson S. Hutton D. Siemienska J. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi Annals of Tropical Medicine & Parasitology 2000 94 8 801 816 10.1080/00034983.2000.11813605 11214099
24 Sironi M. Bandi C. Sacchi L. Di Sacco B. Damiani G. Genchi C. Molecular evidence for a close relative of the arthropod endosymbiont Wolbachia in a filarial worm Molecular and Biochemical Parasitology 1995 74 2 223 227 10.1016/0166-6851(95)02494-8 2-s2.0-0029582938 8719164
25 Mills M. K. McCabe L. G. Rodrigue E. M. Lechtreck K. F. Starai V. J. Wbm0076, a candidate effector protein of the Wolbachia endosymbiont of Brugia malayi, disrupts eukaryotic actin dynamics PLoS Pathogens 2023 19 2, article e1010777 10.1371/journal.ppat.1010777 36800397
26 McGarry H. F. Egerton G. L. Taylor M. J. Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi Molecular and Biochemical Parasitology 2004 135 1 57 67 10.1016/j.molbiopara.2004.01.006 2-s2.0-1842713052 15287587
27 Fenn K. Blaxter M. Quantification of Wolbachia bacteria in Brugia malayi through the nematode lifecycle Molecular Biochemical Parasitology 2004 137 2 361 364 10.1016/j.molbiopara.2004.06.012 2-s2.0-4644364675 15383308
28 Foster J. Ganatra M. Kamal I. The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode PLoS Biology 2005 3 4, article e121 10.1371/journal.pbio.0030121 2-s2.0-21144432943 15780005
29 Hosokawa T. Koga R. Kikuchi Y. Meng X.-Y. Fukatsu T. Wolbachia as a bacteriocyte-associated nutritional mutualist National Academy of Sciences of the United States of America 2010 107 2 769 774 10.1073/pnas.0911476107 2-s2.0-76249087317 20080750
30 Nikoh N. Hosokawa T. Moriyama M. Oshima K. Hattori M. Fukatsu T. Evolutionary origin of insect–Wolbachia nutritional mutualism National Academy of Sciences of the United States of America 2014 111 28 10257 10262 10.1073/pnas.1409284111 2-s2.0-84904336960 24982177
31 Landmann F. Voronin D. Sullivan W. Taylor M. J. Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodes PLoS Pathogens 2011 7 11, article e1002351 10.1371/journal.ppat.1002351 2-s2.0-81755187248 22072969
32 Taylor M. J. Wolbachia endosymbiotic bacteria of filarial nematodes. A new insight into disease pathogenesis and control Archives of Medical Research 2002 33 4 422 424 10.1016/S0188-4409(02)00377-6 2-s2.0-0036662067 12234534
33 Chirgwin S. R. Coleman S. U. Porthouse K. H. Nowling J. M. Punkosdy G. A. Klei T. R. Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus) Infection and Immunity 2003 71 12 6986 6994 10.1128/IAI.71.12.6986-6994.2003 2-s2.0-0345283083 14638788
34 Hoerauf A. Volkmann L. Hamelmann C. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis The Lancet 2000 355 9211 1242 1243 10.1016/S0140-6736(00)02095-X 2-s2.0-0034621005 10770311
35 Hoerauf A. Satoguina J. Saeftel M. Specht S. Immunomodulation by filarial nematodes Parasite Immunology 2005 27 10-11 417 429 10.1111/j.1365-3024.2005.00792.x 2-s2.0-26244438173 16179035
36 Sulaiman W. A. Kamtchum-Tatuene J. Mohamed M. H. Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives Indian Journal of Medical Research 2019 149 6 706 714 10.4103/ijmr.IJMR_454_17 2-s2.0-85071983702 31496523
37 Genchi C. Kramer L. H. Sassera D. Bandi C. Wolbachia and its implications for the immunopathology of filariasis Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 2012 12 1 53 56 10.2174/187153012799279108 2-s2.0-84857135321 22214329
38 Turner J. D. Langley R. S. Johnston K. L. Wolbachia lipoprotein stimulates innate and adaptive immunity through toll-like receptors 2 and 6 to induce disease manifestations of filariasis Journal of Biological Chemistry 2009 284 33 22364 22378 10.1074/jbc.M901528200 2-s2.0-69249119399 19458089
39 Taylor M. J. Cross H. F. Bilo K. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria The Journal of Experimental Medicine 2000 191 8 1429 1436 10.1084/jem.191.8.1429 2-s2.0-0034678425 10770808
40 Turner J. D. Langley R. S. Johnston K. L. Egerton G. Wanji S. Taylor M. J. Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-Specific stimuli in a MyD88/TLR2-dependent manner The Journal of Immunology 2006 177 2 1240 1249 10.4049/jimmunol.177.2.1240 2-s2.0-33745836143 16818783
41 Hise A. G. Daehnel K. Gillette-Ferguson I. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM The Journal of Immunology 2007 178 2 1068 1076 10.4049/jimmunol.178.2.1068 2-s2.0-33846232302 17202370
42 Ehrens A. Hoerauf A. Hübner M. P. Eosinophils in filarial infections: inducers of protection or pathology? Frontiers in Immunology 2022 13, article 983812 10.3389/fimmu.2022.983812 36389745
43 Cross H. F. Haarbrink M. Egerton G. Yazdanbakhsh M. Taylor M. J. Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood The Lancet 2001 358 9296 1873 1875 10.1016/S0140-6736(01)06899-4 2-s2.0-0035657236 11741630
44 Punkosdy G. A. Dennis V. A. Lasater B. L. Tzertzinis G. Foster J. M. Lammie P. J. Detection of serum IgG antibodies specific for Wolbachia surface protein in rhesus monkeys infected with Brugia malayi The Journal of Infectious Diseases 2001 184 3 385 389 10.1086/322023 2-s2.0-0035426041 11443570
45 Taylor M. J. Cross H. F. Ford L. Makunde W. H. Prasad G. Bilo K. Wolbachia bacteria in filarial immunity and disease Parasite Immunology 2001 23 7 401 409 10.1046/j.1365-3024.2001.00400.x 2-s2.0-0034856663 11472559
46 Hoerauf A. Mand S. Fischer K. Doxycycline as a novel strategy against bancroftian filariasis—depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production Medical Microbiology and Immunology 2003 192 4 211 216 10.1007/s00430-002-0174-6 2-s2.0-0142072853 12684759
47 Mand S. Debrah A. Y. Klarmann U. Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial Clinical Infectious Diseases 2012 55 5 621 630 10.1093/cid/cis486 2-s2.0-84864950046 22610930
48 Beutler B. A. TLRs and innate immunity Blood 2009 113 7 1399 1407 10.1182/blood-2008-07-019307 2-s2.0-61849170035 18757776
49 Mukherjee S. Karmakar S. Babu S. P. S. TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review Brazilian Journal of Infectious Diseases 2016 20 2 193 204 10.1016/j.bjid.2015.10.011 2-s2.0-84955615999 26775799
50 Mukherjee S. Mukherjee S. Maiti T. K. Bhattacharya S. Sinha Babu S. P. A novel ligand of toll-like receptor 4 from the sheath of Wuchereria bancrofti microfilaria induces proinflammatory response in macrophages The Journal of Infectious Diseases 2017 215 6 954 965 10.1093/infdis/jix067 2-s2.0-85019655331 28453850
51 Zheng H. Tao Z. Cheng W. Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment The American Journal of Tropical Medicine and Hygiene 1991 45 2 175 181 1877712
52 Winkler S. El Menyawi I. Linnau K. Graninger W. Short report: total serum levels of the nitric oxide derivatives nitrite/nitrate during microfilarial clearance in human filarial disease The American Journal of Tropical Medicine and Hygiene 1998 59 4 523 525 10.4269/ajtmh.1998.59.523 2-s2.0-0031782874 9790422
53 Haarbrink M. Abadi G. Buurman W. Dentener M. Terhell A. Yazdanbakhsh M. Strong association of interleukin-6 and lipopolysaccharide-binding protein with severity of adverse reactions after diethylcarbamazine treatment of microfilaremic patients The Journal of Infectious Diseases 2000 182 2 564 569 10.1086/315735 2-s2.0-0033836225 10915090
54 Olszewski W. L. Jamal S. Lukomska B. Manokaran G. Grzelak I. Immune proteins in peripheral tissue fluid-lymph in patients with filarial lymphedema of the lower limbs Lymphology 1992 25 4 166 171 1284085
55 Karima R. Matsumoto S. Higashi H. Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure Molecular Medicine Today 1999 5 3 123 132 10.1016/S1357-4310(98)01430-0 2-s2.0-0033016573 10203736
56 Dreyer G. Medeiros Z. Netto M. J. Leal N. C. de Castro L. G. Piessens W. F. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes Transactions of the Royal Society of Tropical Medicine and Hygiene 1999 93 4 413 417 10.1016/S0035-9203(99)90140-2 2-s2.0-0032837839 10674092
57 Olszewski W. Jamal S. Manokaran G. Bacteriological studies of blood, tissue fluid, lymph and lymph nodes in patients with acute dermatolymphangioadenitis (DLA) in course of ‘filarial’ lymphedema Acta Tropica 1999 73 3 217 224 10.1016/S0001-706X(99)00029-7 2-s2.0-0032753943 10546838
58 Mand S. Pfarr K. Sahoo P. K. Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine The American Journal of Tropical Medicine and Hygiene 2009 81 4 702 711 10.4269/ajtmh.2009.09-0155 2-s2.0-70349747141 19815891
59 Debrah A. Y. Mand S. Specht S. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis PLoS Pathogens 2006 2 9, article e92 10.1371/journal.ppat.0020092 2-s2.0-33749538083 17044733
60 Rao R. U. Huang Y. Abubucker S. Effects of doxycycline on gene expression in Wolbachia and Brugia malayi adult female worms in vivo Journal of Biomedical Science 2012 19 1 1 15 10.1186/1423-0127-19-21 2-s2.0-84862807409 22212150
61 Holman A. G. Davis P. J. Foster J. M. Carlow C. K. Kumar S. Computational prediction of essential genes in an unculturable endosymbiotic bacterium, Wolbachia of Brugia malayi BMC Microbiology 2009 9 1 1 14 10.1186/1471-2180-9-243 2-s2.0-73849107815 19121223
62 Sharma O. P. Kumar M. S. Essential proteins and possible therapeutic targets of Wolbachia endosymbiont and development of FiloBase-a comprehensive drug target database for Lymphatic filariasis Scientific Reports 2016 6 1, article 19842 10.1038/srep19842 2-s2.0-84955467898 26806463
